These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32310173)

  • 1. Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia.
    Sun Y; Tan L; Xu W; Wang ZT; Hu H; Li JQ; Dong Q; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 75(3):729-737. PubMed ID: 32310173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.
    Kim KY; Kim E; Lee JY;
    Alzheimers Res Ther; 2024 Sep; 16(1):202. PubMed ID: 39267169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.
    Qu Y; Tan CC; Shen XN; Li HQ; Cui M; Tan L; Dong Q; Yu JT;
    Stroke; 2021 Mar; 52(3):896-904. PubMed ID: 33517704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
    Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
    Neurobiol Aging; 2021 Jan; 97():10-17. PubMed ID: 33070094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men.
    Tang R; Buchholz E; Dale AM; Rissman RA; Fennema-Notestine C; Gillespie NA; Hagler DJ; Lyons MJ; Neale MC; Panizzon MS; Puckett OK; Reynolds CA; Franz CE; Kremen WS; Elman JA
    Alzheimers Res Ther; 2024 Apr; 16(1):90. PubMed ID: 38664843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light protein in blood predicts regional atrophy in Huntington disease.
    Johnson EB; Byrne LM; Gregory S; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RA; Zetterberg H; Tabrizi SJ; Scahill RI; Wild EJ;
    Neurology; 2018 Feb; 90(8):e717-e723. PubMed ID: 29367444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease.
    Chong JR; Hilal S; Ashton NJ; Karikari TK; Reilhac A; Vrooman H; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP
    Alzheimers Dement (Amst); 2023; 15(1):e12396. PubMed ID: 36994314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
    Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
    Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
    Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
    JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
    Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
    Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults.
    Hu H; Chen KL; Ou YN; Cao XP; Chen SD; Cui M; Dong Q; Tan L; Yu JT;
    Aging (Albany NY); 2019 Sep; 11(17):6904-6914. PubMed ID: 31514172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
    Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
    Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical White Matter Hyperintensities Markedly Impact Plasma Neurofilament Light Chain Variability in GRN Patients.
    Vítor J; Saracino D; Ströer S; Camuzat A; Dorgham K; Clot F; Martin-Hardy P; Pasquier F; ; Le Ber I
    J Alzheimers Dis; 2023; 94(4):1351-1360. PubMed ID: 37393503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults: The Cardiovascular Health Study.
    Fohner AE; Bartz TM; Tracy RP; Adams HHH; Bis JC; Djousse L; Satizabal CL; Lopez OL; Seshadri S; Mukamal KJ; Kuller LH; Psaty BM; Longstreth WT
    Neurology; 2022 Mar; 98(9):e903-e911. PubMed ID: 34921102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.